What are the recommended treatments for hand and palm atopic dermatitis?

Treatment for Hand and Palm Eczema

Begin with aggressive moisturization and topical anti-inflammatory therapy using topical corticosteroids or calcineurin inhibitors as first-line treatment, combined with strict avoidance of irritants and allergens. 1, 2

Initial Management Approach

Skin Barrier Protection and Moisturization

• Apply moisturizers immediately after every hand washing using products packaged in tubes (not jars) to prevent contamination 1
• Use fragrance-free, dye-free, and preservative-free moisturizers to minimize allergic reactions 1
• Carry pocket-sized moisturizers for frequent reapplication throughout the day 1
• Implement "soak and smear" technique nightly: soak hands in plain water for 20 minutes, then immediately apply moisturizer to damp skin for up to 2 weeks 1
• At night, apply thick moisturizer followed by cotton or loose plastic gloves to create an occlusive barrier 1

Hand Hygiene Modifications

• Wash hands with lukewarm or cool water (avoid hot water which damages the skin barrier) for at least 20 seconds 1
• Use gentle synthetic detergents with added moisturizers, avoiding allergenic surfactants, preservatives, fragrances, or dyes 1
• Pat dry gently without rubbing 1
• Avoid antibacterial soaps as they are unnecessary and more irritating 1

Topical Anti-Inflammatory Therapy

First-Line Prescription Treatment

• Topical corticosteroids remain the mainstay treatment for active hand eczema 2, 3
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are strongly recommended as steroid-sparing alternatives 2
• Topical JAK inhibitors (ruxolitinib cream) show significant efficacy with improved IGA-TS and EASI75 scores at 4-8 weeks 2, 4
• Topical PDE-4 inhibitors (roflumilast cream 0.15%) are strongly recommended, showing moderate improvement in disease severity and pruritus with minimal adverse effects 5, 2

Maintenance Therapy to Prevent Flares

• Apply topical corticosteroids 1-2 times per week to previously involved skin after achieving disease control 6
• Apply topical calcineurin inhibitors 2-3 times per week to previously affected areas for maintenance 6

Identifying and Managing Underlying Causes

Distinguish Between Subtypes

• For irritant contact dermatitis (ICD): identify and avoid irritants including wet work, surfactants, detergents, bleach, and dish soap 1
• For allergic contact dermatitis (ACD): perform patch testing to identify clinically relevant allergens, then strictly avoid them 1, 6
• Avoid topical antibiotics (neomycin, bacitracin) which are common allergens 1
• For atopic hand dermatitis: recognize this as a manifestation of atopic dermatitis requiring systemic consideration 7, 8

Glove Use Recommendations

• For glove-related ACD, use accelerator-free gloves such as rubber-free neoprene or nitrile gloves 1
• Apply moisturizer before wearing gloves 1
• Consider cotton glove liners under protective gloves 1
• Use water-based moisturizers under all glove types; oil-based products can break down latex and rubber 1

Advanced Treatment for Recalcitrant Cases

When to Escalate Therapy

If conservative measures fail after optimizing topical therapy and basic management, consider alternative diagnoses (contact dermatitis, cutaneous lymphoma) and escalate to systemic therapy 5, 2

Systemic Treatment Options

• Dupilumab (IL-4/IL-13 inhibitor) shows 80.3% response rate in chronic hand eczema within 4-16 weeks, with strong evidence for moderate-to-severe atopic hand dermatitis 9, 10
• Oral JAK inhibitors (abrocitinib, baricitinib, upadacitinib) receive strong recommendations for severe atopic dermatitis affecting the hands 9
• Lebrikizumab (IL-13 inhibitor) is FDA-approved for moderate-to-severe atopic dermatitis in patients ≥12 years 5
• Phototherapy is conditionally recommended for recalcitrant cases 9
• Cyclosporine (3-5 mg/kg/day) is conditionally recommended for short-term use (up to 1 year) 9
• Methotrexate, azathioprine, and mycophenolate are conditionally recommended as alternatives 9

Topical Delgocitinib

• Topical delgocitinib is the only FDA-approved medication specifically for chronic hand eczema in patients who have not responded to or cannot use topical corticosteroids 11, 12

Common Pitfalls to Avoid

• Do not use systemic corticosteroids (conditional recommendation against due to rebound and adverse effects) 9
• Avoid washing hands with very hot or very cold water 1
• Do not use disinfectant wipes to clean hands 1
• Avoid prolonged glove occlusion without underlying moisturizer application 1
• Do not apply topical steroids before glove occlusion without moisturizer 1
• Avoid food elimination diets based solely on allergy testing without clinical correlation 6
• Be cautious with prolonged topical steroid use as it can cause skin barrier damage 1

When to Refer to Dermatology

• Recalcitrant hand dermatitis despite optimized topical therapy 1
• Suspected allergic contact dermatitis requiring patch testing 1, 6
• Need for phototherapy or systemic immunosuppressive therapy 1
• Consideration for occupational modification or worker's compensation evaluation 3, 11